Bioasis Technologies Stock Working Capital
| BIOAF Stock | USD 0 0.00 0.00% |
biOasis Technologies fundamentals help investors to digest information that contributes to BiOasis Technologies' financial success or failures. It also enables traders to predict the movement of BiOasis Pink Sheet. The fundamental analysis module provides a way to measure BiOasis Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BiOasis Technologies pink sheet.
BiOasis |
biOasis Technologies Company Working Capital Analysis
BiOasis Technologies' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current BiOasis Technologies Working Capital | 437 K |
Most of BiOasis Technologies' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, biOasis Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, biOasis Technologies has a Working Capital of 437 K. This is 99.9% lower than that of the Biotechnology sector and 99.92% lower than that of the Health Care industry. The working capital for all United States stocks is 99.97% higher than that of the company.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
BiOasis Fundamentals
| Return On Asset | -0.81 | |||
| Operating Margin | (11.41) % | |||
| Current Valuation | 6 M | |||
| Shares Outstanding | 79.41 M | |||
| Shares Owned By Insiders | 2.05 % | |||
| Price To Earning | 13.82 X | |||
| Price To Book | 53.47 X | |||
| Price To Sales | 26.52 X | |||
| Revenue | 37.73 K | |||
| Gross Profit | (1.15 M) | |||
| EBITDA | (3.54 M) | |||
| Net Income | (2.96 M) | |||
| Cash And Equivalents | 764.97 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 401.76 K | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 0.38 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (3.64 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 0.58 | |||
| Number Of Employees | 23 | |||
| Beta | 0.39 | |||
| Market Capitalization | 2.13 M | |||
| Total Asset | 2.27 M | |||
| Retained Earnings | (18.69 M) | |||
| Working Capital | 437 K | |||
| Current Asset | 874 K | |||
| Current Liabilities | 437 K | |||
| Z Score | -11.5 | |||
| Net Asset | 2.27 M |
About BiOasis Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze biOasis Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiOasis Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of biOasis Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BiOasis Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BiOasis Technologies' short interest history, or implied volatility extrapolated from BiOasis Technologies options trading.
Pair Trading with BiOasis Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiOasis Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will appreciate offsetting losses from the drop in the long position's value.Moving against BiOasis Pink Sheet
| 0.46 | PTAIF | PT Astra International | PairCorr |
| 0.41 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
The ability to find closely correlated positions to BiOasis Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiOasis Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiOasis Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling biOasis Technologies to buy it.
The correlation of BiOasis Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiOasis Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if biOasis Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiOasis Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in biOasis Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the biOasis Technologies information on this page should be used as a complementary analysis to other BiOasis Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for BiOasis Pink Sheet analysis
When running BiOasis Technologies' price analysis, check to measure BiOasis Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiOasis Technologies is operating at the current time. Most of BiOasis Technologies' value examination focuses on studying past and present price action to predict the probability of BiOasis Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiOasis Technologies' price. Additionally, you may evaluate how the addition of BiOasis Technologies to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |